State immunization and cancer registries contain data that, if linked, could be used to monitor the impact of human papillomavirus (HPV) vaccine on cervical cancer and precancer. Michigan is uniquely positioned to examine these outcomes using two population-based resources: the state-wide cancer registry and immunization information system (IIS). We assessed the feasibility of identifying females in the IIS who had continuous Michigan residence and linking them to the cancer registry. We considered continuous residence necessary for future studies of vaccine impact to avoid misclassifying those who may have been immunized while residing out-of-state and whose immunization therefore may not have been reported in Michigan. We identified femal...
Human papillomavirus (HPV) vaccines are available in the United States and around the world to preve...
Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (A...
Background.Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which cause 70% of c...
State immunization and cancer registries contain data that, if linked, could be used to monitor the ...
PurposeThe USA has a well-established network of central cancer registries (CCRs) that collect data ...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since...
Human papillomavirus (HPV) causes approximately 30,000 cancers in the United States annually (1). HP...
Background:Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but ...
Background: HPV vaccines have demonstrated high efficacy in clinical trials against cervical lesions...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
We tested the hypothesis that states with higher rates of cancers associated with human papillomavir...
We tested the hypothesis that states with higher rates of cancers associated with human papillomavir...
Background: Cervical cancer prevention programs are being reconfigured to incorporate human papillo-...
Increased cases of Human Papillomavirus (HPV) related cancers and low HPV vaccine uptake are public ...
Human papillomavirus (HPV) vaccines are available in the United States and around the world to preve...
Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (A...
Background.Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which cause 70% of c...
State immunization and cancer registries contain data that, if linked, could be used to monitor the ...
PurposeThe USA has a well-established network of central cancer registries (CCRs) that collect data ...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
Nationwide positivity rates of high-risk human papillomavirus for the United States before and since...
Human papillomavirus (HPV) causes approximately 30,000 cancers in the United States annually (1). HP...
Background:Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but ...
Background: HPV vaccines have demonstrated high efficacy in clinical trials against cervical lesions...
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release ...
We tested the hypothesis that states with higher rates of cancers associated with human papillomavir...
We tested the hypothesis that states with higher rates of cancers associated with human papillomavir...
Background: Cervical cancer prevention programs are being reconfigured to incorporate human papillo-...
Increased cases of Human Papillomavirus (HPV) related cancers and low HPV vaccine uptake are public ...
Human papillomavirus (HPV) vaccines are available in the United States and around the world to preve...
Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (A...
Background.Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which cause 70% of c...